10x Genomics, Inc. financial data

Symbol
TXG on Nasdaq
Industry
Laboratory Analytical Instruments
Location
6230 Stoneridge Mall Road, Pleasanton, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 507 % -4.4%
Quick Ratio 76 % +4.78%
Debt-to-equity 29 % +6.9%
Return On Equity -25.4 % +23.3%
Return On Assets -19.7 % +24.4%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 122M shares +2.68%
Entity Public Float 1.8B USD -68.4%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 120M shares +2.81%
Weighted Average Number of Shares Outstanding, Diluted 120M shares +2.81%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 611M USD -1.28%
Cost of Revenue 196M USD -6.26%
Operating Income (Loss) -195M USD +26.7%
Nonoperating Income (Expense) 16.9M USD +1.77%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -178M USD +28.6%
Income Tax Expense (Benefit) 4.93M USD -22.2%
Net Income (Loss) Attributable to Parent -183M USD +28.4%
Earnings Per Share, Basic -1.52 USD/shares +30.3%
Earnings Per Share, Diluted -1.52 USD/shares +30.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 344M USD -4.24%
Accounts Receivable, after Allowance for Credit Loss, Current 87.9M USD -23.5%
Inventory, Net 83.1M USD +12.8%
Assets, Current 584M USD -1.95%
Property, Plant and Equipment, Net 253M USD -9.63%
Operating Lease, Right-of-Use Asset 57.3M USD -12.3%
Intangible Assets, Net (Excluding Goodwill) 15.7M USD -5.69%
Goodwill 4.51M USD 0%
Other Assets, Noncurrent 4.13M USD +34.8%
Assets 919M USD -4.82%
Accounts Payable, Current 12.9M USD -18%
Employee-related Liabilities, Current 33.6M USD +11.7%
Contract with Customer, Liability, Current 20.7M USD +57.1%
Liabilities, Current 118M USD -7.49%
Contract with Customer, Liability, Noncurrent 12.5M USD +42%
Operating Lease, Liability, Noncurrent 73.3M USD -12.5%
Other Liabilities, Noncurrent 5.03M USD +17.6%
Liabilities 209M USD -6.96%
Accumulated Other Comprehensive Income (Loss), Net of Tax -493K USD -14.9%
Retained Earnings (Accumulated Deficit) -1.47B USD -14.2%
Stockholders' Equity Attributable to Parent 710M USD -4.17%
Liabilities and Equity 919M USD -4.82%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -15.7M USD -281%
Net Cash Provided by (Used in) Financing Activities 1.64M USD
Net Cash Provided by (Used in) Investing Activities 10.6M USD -91.1%
Common Stock, Shares Authorized 1.1B shares 0%
Common Stock, Shares, Issued 122M shares +2.68%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.5M USD -103%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 344M USD -4.24%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 479M USD +8.21%
Deferred Tax Assets, Gross 496M USD +7.76%
Operating Lease, Liability 82.6M USD -13.4%
Payments to Acquire Property, Plant, and Equipment 2.91M USD -36.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -183M USD +27.3%
Lessee, Operating Lease, Liability, to be Paid 101M USD -15.1%
Property, Plant and Equipment, Gross 376M USD -1.94%
Operating Lease, Liability, Current 9.29M USD -19.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 15.4M USD +3.18%
Lessee, Operating Lease, Liability, to be Paid, Year One 13.9M USD -17%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 18.6M USD -22%
Lessee, Operating Lease, Liability, to be Paid, Year Three 15.6M USD +0.85%
Deferred Tax Assets, Operating Loss Carryforwards 162M USD -2.96%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100M shares 0%
Unrecognized Tax Benefits 50M USD +9.43%
Lessee, Operating Lease, Liability, to be Paid, Year Four 15.7M USD +0.63%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 9.19M USD +41.8%
Deferred Tax Assets, Net of Valuation Allowance 16.7M USD -3.79%
Share-based Payment Arrangement, Expense 141M USD -15.7%
Interest Expense 15K USD -95.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%